Endocuff-assisted Versus Cap-assisted Versus Standard Colonoscopy (EC-Cap-SC)

February 10, 2019 updated by: Tobias Meister, Helios Albert-Schweitzer-Klinik Northeim

Endocuff-assisted Versus Cap-assisted Versus Standard Colonoscopy for Adenoma Detection: A Randomized Controlled European Multicenter Study

Comparison of Endocuff-assisted, Cap-assisted and Standard colonoscopy for assessment of the adenoma detection rate (ADR)

Study Overview

Detailed Description

The Endocuff is a medical device, approved in 2012 by the American Food and Drug Administration, which was also authorized by the European Agency for the Evaluation of Medicinal Products. The aim of the cuff is to optimize the view of the colonic mucosa. There is also a transparent cap on the market, which is used in colonoscopy for a better evaluation of the mucosa and polyp detection. The goal of this project is to conduct a prospective randomized trial for clarification of the hypotheses, whether the usage of the Endocuff increases the detection rate of adenomas compared to the transparent cap or compared to standard colonoscopy.

Study Type

Interventional

Enrollment (Actual)

561

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Göttingen, Germany, 37075
        • University Medical Center Göttingen
      • Helmstedt, Germany
        • Helios St. Marienberg Klinik Helmstedt
      • Northeim, Germany, 37154
        • HELIOS Albert-Schweitzer-Klinik
      • Siegburg, Germany
        • HELIOS Medical Center Siegburg
    • North-Rhine Westphalia
      • Muenster, North-Rhine Westphalia, Germany, 48149
        • University of Muenster
      • Wroclaw, Poland, 50-556
        • Wroclaw Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Colonoscopy independent from indication
  • Age ≥ 18
  • Patient is able to provide informed consent for the procedure

Exclusion Criteria:

  • Inflammatory Bowel Disease stenosis
  • Pregnant of nursing patient
  • Acute diverticulitis
  • Active Inflammatory Bowel Disease
  • Age ≤ 18
  • Coagulation disorder (INR>1.4 , Thrombocytes < 50000/µl)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Arc Endocuff (AEC 110, 120, 130, 140)
Endocuff-assisted colonoscopy Colonoscopy with the Endocuff attached at the distal tip of the scope
Active Comparator: Cap
Cap-assisted colonoscopy Colonoscopy with the transparent Cap attached at the distal tip of the scope
Olympus Disposable distal attachment 15mm diameter, 4mm depth
Active Comparator: Standard Colonoscope
Standard colonoscopy without any additional device

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adenoma detection rate
Time Frame: 1 year
Proportion of patients having at least one adenoma
1 year
Polyp detection rate
Time Frame: 1 year
Proportion of patients having at least one adenoma
1 year

Secondary Outcome Measures

Outcome Measure
Time Frame
Bowel preparation result
Time Frame: one day
one day
Coecum intubation rate
Time Frame: one year
one year
Ileum intubation rate
Time Frame: one year
one year
Coecum intubation time
Time Frame: one day
one day
withdrawal time
Time Frame: one day
one day
mucosal laceration
Time Frame: one day
one day
severe bleeding
Time Frame: one day
one day
perforation
Time Frame: one day
one day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tobias Meister, Prof. Dr.med., Helios Albert-Schweitzer-Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2015

Primary Completion (Actual)

February 1, 2019

Study Completion (Actual)

February 1, 2019

Study Registration Dates

First Submitted

January 2, 2015

First Submitted That Met QC Criteria

January 5, 2015

First Posted (Estimate)

January 6, 2015

Study Record Updates

Last Update Posted (Actual)

February 12, 2019

Last Update Submitted That Met QC Criteria

February 10, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colorectal Polyps

3
Subscribe